Paula Silva Felicio - Concepedia

Author

Paula Silva Felicio

Hospital de Câncer de Barretos ORCID

Also Known As

Felicio, Paula Silva, P. Felicio, Paula S. Felicio, Paula Silva Felicio

Publications

223

Citations

H-Index

Concepts

All Affiliations

Hospital de Câncer de Barretos AC Camargo Hospital University of Minho Hospital São Paulo Genomic (Brazil)

About

Paula Silva Felicio is an author at Hospital de Câncer de Barretos specializing in molecular diagnostics, cancer genetics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	86
2	Pathology	3	3	86
3	Cancer Genetics	3	3	86
4	Public Health	2	2	76
5	Genetic Epidemiology	2	2	76

Paula Silva Felicio

Publications

198

Citations

H-Index

Page 1

	Year	Citations
Prevalence of <i>BRCA1/BRCA2</i> mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry Gabriela Carvalho Fernandes, Rodrigo Augusto Depieri Michelli, Henrique C.R. Galvão, Oncotarget	2016	77
Whole‐exome sequencing of non‐ <i>BRCA1/BRCA2</i> mutation carrier cases at high‐risk for hereditary breast/ovarian cancer Paula Silva Felicio, Rebeca Silveira Grasel, Natália Campacci, Human Mutation Current StudyCancer RiskWhole‐exome SequencingGeneticsHereditary Breast	2020	61
Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer Giovana Tardin Torrezan, Fernanda G. dos Santos R. de Almeida, Márcia CP Figueiredo, Frontiers in Genetics	2018	23
Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer Renan Gomes, Bárbara Luísa Soares, Paula Silva Felicio, Genetics and Molecular Biology GeneticsGenetic EpidemiologyHuman PolymorphismPathologyHaplotypic Characterization	2020	15
Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients Rebeca Silveira Grasel, Paula Silva Felicio, André Escremim de Paula, Frontiers in Oncology	2020	12
The Brazilian TP53 mutation (R337H) and sarcomas Sáhlua Miguel Volc, Cíntia Regina Niederauer Ramos, Henrique de Campos Reis Galvão, PLoS ONE Tumor BiologyTumoral PathologyOncologySomatic VariantMedicine	2020	10

Page 1